Bain Capital and Cinven completed the acquisition of a 28% stake in STADA Arzneimittel for 1.5bn.

Bain Capital, an American private investment firm, and Cinven, a global private equity firm, completed the acquisition of a 28% stake in STADA Arzneimittel, a pharmaceutical company, for £1.5bn.